The clinical performance is complex and often involves multi-systematic fatigue. Early identification and standardized diagnosis are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of the treatment of quality of life of the PF-ILD requires individualized development, usually including pharmacotherapy, rehabilitation, regular follow-up, and multidimensional management. In recent years, with the development of treatment-focused, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions and timely adjustment to changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of the quality of life associated with PF-ILD. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.